IGFN1
gene geneOn this page
Also known as DKFZp434B1231EEF1A2BP1
Summary
IGFN1 (immunoglobulin like and fibronectin type III domain containing 1, HGNC:24607) is a protein-coding gene on chromosome 1q32.1, encoding Immunoglobulin-like and fibronectin type III domain-containing protein 1 (Q86VF2).
Predicted to act upstream of or within myoblast differentiation and myoblast fusion. Predicted to be located in Z disc and nucleus.
Source: NCBI Gene 91156 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 901 total
- MANE Select transcript:
NM_001164586
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24607 |
| Approved symbol | IGFN1 |
| Name | immunoglobulin like and fibronectin type III domain containing 1 |
| Location | 1q32.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp434B1231, EEF1A2BP1 |
| Ensembl gene | ENSG00000163395 |
| Ensembl biotype | protein_coding |
| OMIM | 617309 |
| Entrez | 91156 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 2 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000295591, ENST00000335211, ENST00000437879, ENST00000444705, ENST00000473483
RefSeq mRNA: 2 — MANE Select: NM_001164586
NM_001164586, NM_001367841
CCDS: CCDS53455, CCDS91141
Canonical transcript exons
ENST00000335211 — 24 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001074099 | 201215539 | 201215838 |
| ENSE00003465531 | 201215013 | 201215154 |
| ENSE00003468111 | 201226882 | 201227208 |
| ENSE00003490815 | 201216454 | 201216753 |
| ENSE00003519041 | 201218530 | 201218658 |
| ENSE00003553285 | 201214177 | 201214301 |
| ENSE00003564195 | 201228386 | 201228952 |
| ENSE00003568533 | 201206083 | 201213621 |
| ENSE00003577685 | 201217287 | 201217460 |
| ENSE00003595406 | 201224679 | 201224874 |
| ENSE00003619443 | 201221444 | 201221746 |
| ENSE00003638486 | 201205082 | 201205354 |
| ENSE00003645213 | 201222739 | 201222827 |
| ENSE00003718291 | 201200237 | 201200411 |
| ENSE00003725291 | 201203738 | 201203906 |
| ENSE00003727529 | 201199334 | 201199378 |
| ENSE00003728565 | 201197218 | 201197317 |
| ENSE00003729169 | 201193247 | 201193300 |
| ENSE00003735447 | 201194154 | 201194273 |
| ENSE00003736930 | 201199609 | 201199654 |
| ENSE00003738745 | 201201719 | 201201832 |
| ENSE00003746968 | 201195839 | 201195978 |
| ENSE00003748595 | 201225824 | 201226123 |
| ENSE00003897309 | 201190824 | 201190907 |
Expression profiles
Bgee: expression breadth ubiquitous, 154 present calls, max score 94.01.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.8094 / max 330.2967, expressed in 171 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 7679 | 1.7535 | 166 |
| 7678 | 0.0559 | 22 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gastrocnemius | UBERON:0001388 | 94.01 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 93.88 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 93.50 | gold quality |
| thyroid gland | UBERON:0002046 | 92.55 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 91.48 | gold quality |
| muscle of leg | UBERON:0001383 | 91.28 | gold quality |
| kidney epithelium | UBERON:0004819 | 90.40 | gold quality |
| tibialis anterior | UBERON:0001385 | 88.36 | silver quality |
| quadriceps femoris | UBERON:0001377 | 86.16 | silver quality |
| vastus lateralis | UBERON:0001379 | 86.06 | silver quality |
| body of pancreas | UBERON:0001150 | 85.58 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.36 | silver quality |
| left ventricle myocardium | UBERON:0006566 | 83.73 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 83.65 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 83.65 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 83.11 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 82.55 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 82.46 | gold quality |
| deltoid | UBERON:0001476 | 82.13 | gold quality |
| muscle tissue | UBERON:0002385 | 80.81 | gold quality |
| myocardium | UBERON:0002349 | 80.67 | gold quality |
| superficial temporal artery | UBERON:0001614 | 79.42 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 75.94 | gold quality |
| biceps brachii | UBERON:0001507 | 75.40 | silver quality |
| upper arm skin | UBERON:0004263 | 74.06 | gold quality |
| pancreas | UBERON:0001264 | 73.52 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 73.51 | silver quality |
| left testis | UBERON:0004533 | 72.28 | gold quality |
| sperm | CL:0000019 | 71.98 | gold quality |
| parotid gland | UBERON:0001831 | 71.72 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.05 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- a model in which this increased expression of IGFN1 serves to down-regulate protein synthesis via interaction with eEF1A during denervation. (PMID:18756455)
- A novel variant, c.6196A>G in the IGFN1 gene, was significantly associated with only Polypoidal choroidal vasculopathy (combined p = 7.1 x 10(-11) , odds ratio = 9.44), but not with neovascular age-related macular degeneration(combined p = 0.683, odds ratio = 1.30). (PMID:29323771)
- Study results in UOK146 renal cell carcinoma cell line provide evidence of novel splicing in intron 15 of IGFN1 leading to the formation of two more alternative spliced isoforms. Potential G-quadruplex forming sequence (PQS) in this intron forms a stable G-quadruplex which is involved in the alternative splicing and regulates splicing efficiency. (PMID:30335789)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Igfn1 | ENSMUSG00000051985 |
| rattus_norvegicus | Igfn1 | ENSRNOG00000026087 |
| drosophila_melanogaster | bt | FBGN0005666 |
| caenorhabditis_elegans | WBGENE00001000 | |
| caenorhabditis_elegans | WBGENE00006759 | |
| caenorhabditis_elegans | unc-89 | WBGENE00006820 |
Paralogs (9): SPEG (ENSG00000072195), MYOT (ENSG00000120729), PALLD (ENSG00000129116), ALPK3 (ENSG00000136383), MYPN (ENSG00000138347), HMCN1 (ENSG00000143341), OBSCN (ENSG00000154358), CCDC141 (ENSG00000163492), SPEGNB (ENSG00000286095)
Protein
Protein identifiers
Immunoglobulin-like and fibronectin type III domain-containing protein 1 — Q86VF2 (reviewed: Q86VF2)
Alternative names: EEF1A2-binding protein 1, KY-interacting protein 1
All UniProt accessions (1): Q86VF2
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with FLNC. Interacts with KY.
Subcellular location. Nucleus. Cytoplasm. Myofibril. Sarcomere. Z line.
Tissue specificity. Expressed in skeletal muscle.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q86VF2-1 | 1 | yes |
| Q86VF2-2 | 2 | |
| Q86VF2-3 | 3 | |
| Q86VF2-4 | 4 | |
| Q86VF2-5 | 5 |
RefSeq proteins (2): NP_001158058, NP_001354770 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003598 | Ig_sub2 | Domain |
| IPR003599 | Ig_sub | Domain |
| IPR003961 | FN3_dom | Domain |
| IPR007110 | Ig-like_dom | Domain |
| IPR013098 | Ig_I-set | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036116 | FN3_sf | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR040849 | MyBP-C_THB | Domain |
| IPR050964 | Striated_Muscle_Regulatory | Family |
Pfam: PF00041, PF07679, PF18362
UniProt features (24 total): domain 9, splice variant 7, region of interest 2, compositionally biased region 2, sequence variant 2, chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86VF2-F1 | 77.48 | 0.23 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
GOCC_I_BAND, FORTSCHEGGER_PHF8_TARGETS_DN, GOCC_SUPRAMOLECULAR_COMPLEX, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP, GOCC_SUPRAMOLECULAR_POLYMER, MIR6764_5P, MIR665, BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP, MANNO_MIDBRAIN_NEUROTYPES_HGABA, DESCARTES_MAIN_FETAL_CCL19_CCL21_POSITIVE_CELLS, DESCARTES_FETAL_ADRENAL_STROMAL_CELLS, DESCARTES_FETAL_KIDNEY_STROMAL_CELLS, DESCARTES_FETAL_PANCREAS_CCL19_CCL21_POSITIVE_CELLS, ZNF490_TARGET_GENES, NOURUZI_NEPC_ASCL1_TARGETS
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): nucleus (GO:0005634), Z disc (GO:0030018), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| I band | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
1288 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IGFN1 | FLNC | Q14315 | 664 |
| IGFN1 | COBL | O75128 | 528 |
| IGFN1 | MSS51 | Q4VC12 | 452 |
| IGFN1 | FSIP2 | Q5CZC0 | 420 |
| IGFN1 | OSBPL3 | Q9H4L5 | 409 |
| IGFN1 | FRAS1 | Q86XX4 | 406 |
| IGFN1 | FNDC10 | F2Z333 | 401 |
| IGFN1 | FNDC7 | Q5VTL7 | 380 |
| IGFN1 | OR2W1 | Q9Y3N9 | 379 |
| IGFN1 | PRAMEF13 | Q5VWM6 | 378 |
| IGFN1 | MUC12 | Q9UKN1 | 367 |
| IGFN1 | NKAIN1 | Q4KMZ8 | 356 |
| IGFN1 | OR2T12 | Q8NG77 | 351 |
| IGFN1 | KCNG4 | Q8TDN1 | 349 |
| IGFN1 | OR5T1 | Q8NG75 | 348 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MEOX2 | IGFN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IGFN1 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLHL25 | IGFN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRPS1 | MTA2 | psi-mi:“MI:0914”(association) | 0.530 |
| GAREM1 | IGFN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | IGFN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| IGFN1 | HSPD1 | psi-mi:“MI:0914”(association) | 0.350 |
| ATP6V0A4 | ATP6V0C | psi-mi:“MI:0914”(association) | 0.350 |
| GPC3 | PXDNL | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (46): IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid), IGFN1 (Two-hybrid)
ESM2 similar proteins: A1A5C7, A6NCF5, A6QLN9, A8MUP2, D3YYU8, D3ZZ80, F1LTR1, O75147, O88843, P08887, Q28D01, Q3SZQ2, Q3UHH2, Q3ZCW2, Q4R539, Q5EA19, Q5R4Q7, Q5R5K6, Q5RCI5, Q5RFN0, Q5SP67, Q5ZHQ2, Q642A6, Q67FW5, Q6AZB0, Q6IA17, Q6PCB0, Q7TPB4, Q86TI4, Q86VF2, Q8BGR6, Q8BZI6, Q8C6G8, Q8N5I2, Q8N653, Q8R2Z5, Q8VE98, Q8VED9, Q969P0, Q96NJ5
Diamond homologs: A2ASS6, A2CG49, A4IFM7, A8C984, A8X6H4, E9PT87, F1M0Z1, O02827, O14936, O43293, O44997, O49717, O54784, O60229, O70589, O75962, O80673, O88764, O94768, P07313, P08414, P0C5E3, P11801, P13234, P20689, P25323, P53355, P53681, P53684, P70402, P93759, P97924, Q05623, Q06850, Q0KL02, Q0V7M1, Q10KY3, Q13203, Q14012, Q16566
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
901 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 752 |
| Likely benign | 124 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3771 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:201190905:CAGGT:C | donor_loss | 1.0000 |
| 1:201190906:AGGTA:A | donor_loss | 1.0000 |
| 1:201190908:GTA:G | donor_loss | 1.0000 |
| 1:201193243:TCA:T | acceptor_loss | 1.0000 |
| 1:201193244:CAGG:C | acceptor_loss | 1.0000 |
| 1:201193246:G:GC | acceptor_loss | 1.0000 |
| 1:201193299:AGG:A | donor_loss | 1.0000 |
| 1:201193301:GT:G | donor_loss | 1.0000 |
| 1:201193302:T:A | donor_loss | 1.0000 |
| 1:201194142:T:TA | acceptor_gain | 1.0000 |
| 1:201194270:GAGG:G | donor_gain | 1.0000 |
| 1:201194272:GG:G | donor_gain | 1.0000 |
| 1:201194273:GG:G | donor_gain | 1.0000 |
| 1:201195834:TGCA:T | acceptor_loss | 1.0000 |
| 1:201195836:CAGGG:C | acceptor_loss | 1.0000 |
| 1:201195837:A:AG | acceptor_gain | 1.0000 |
| 1:201195837:AG:A | acceptor_gain | 1.0000 |
| 1:201195837:AGGGA:A | acceptor_loss | 1.0000 |
| 1:201195838:G:A | acceptor_loss | 1.0000 |
| 1:201195838:G:GG | acceptor_gain | 1.0000 |
| 1:201195838:GG:G | acceptor_gain | 1.0000 |
| 1:201195975:GCAG:G | donor_gain | 1.0000 |
| 1:201195977:AGGTA:A | donor_loss | 1.0000 |
| 1:201195978:GGT:G | donor_loss | 1.0000 |
| 1:201195979:G:GG | donor_gain | 1.0000 |
| 1:201195980:T:G | donor_loss | 1.0000 |
| 1:201199289:T:A | acceptor_gain | 1.0000 |
| 1:201199293:T:A | acceptor_gain | 1.0000 |
| 1:201199298:A:AG | acceptor_gain | 1.0000 |
| 1:201199298:ACATC:A | acceptor_gain | 1.0000 |
AlphaMissense
23960 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000053111 (1:201221273 G>T), RS1000104375 (1:201191078 C>T), RS1000138379 (1:201215802 G>T), RS1000205792 (1:201216932 C>T), RS1000313065 (1:201199720 A>G), RS1000536969 (1:201198126 C>T), RS1000606566 (1:201221297 C>A), RS1000606938 (1:201192784 C>T), RS1000653436 (1:201198387 C>A,T), RS1000670373 (1:201194126 C>A,T), RS1000757318 (1:201212302 A>G,T), RS1000805061 (1:201205064 T>C), RS1000901008 (1:201202734 T>A,C), RS1001033863 (1:201203511 C>G,T), RS1001182307 (1:201197123 C>T)
Disease associations
OMIM: gene MIM:617309 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005212_6 | Asthma | 2.000000e-06 |
| GCST008163_627 | Height | 9.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation, increases mutagenesis | 2 |
| aristolochic acid I | decreases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| sulforaphane | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| abrine | increases expression | 1 |
| bisphenol S | decreases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Methapyrilene | decreases methylation | 1 |
| Oxygen | increases expression | 1 |
| Rotenone | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Gold Compounds | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.